Rapamycin ameliorates brain damage and maintains mitochondrial dynamic balance in diabetic rats subjected to middle cerebral artery occlusion

Metab Brain Dis. 2023 Feb;38(2):409-418. doi: 10.1007/s11011-022-01020-6. Epub 2022 Jun 7.

Abstract

To investigate the effect of rapamycin on mitochondrial dynamic balance in diabetic rats subjected to cerebral ischemia-reperfusion injury. Male Sprague Dawley (SD) rats (n = 78) were treated with high fat diet combined with streptozotocin injection to construct diabetic model in rats. Transient middle cerebral artery occlusion (MCAO) of 2 hours was induced and the brains were harvested after 1 and 3 days of reperfusion. Rapamycin was injected intraperitoneally for 3 days prior to and immediately after operation, once a day. The neurological function was assessed, infarct volumes were measured and HE staining as well as immunohistochemistry were performed. The protein of hippocampus was extracted and Western blotting were performed to detect the levels of mTOR, mitochondrial dynamin related proteins (DRP1, p-DRP1, OPA1), SIRT3, and Nix/BNIP3L. Diabetic hyperglycemia worsened the neurological function performance (p < 0.01), enlarged infarct size (p < 0.01) and increased ischemic neuronal cell death (p < 0.01). The increased damage was associated with elevations of p-mTOR, p-S6, and p-DRP1; and suppressions of SIRT3 and Nix/BNIP3L. Rapamycin ameliorated diabetes-enhanced ischemic brain damage and reversed the biomarker alterations caused by diabetes. High glucose activated mTOR pathway and caused mitochondrial dynamics toward fission. The protective effect of rapamycin against diabetes-enhanced ischemic brain damage was associated with inhibiting mTOR pathway, redressing mitochondrial dynamic imbalance, and elevating SIRT3 and Nix/BNIP3L expression.

Keywords: Cerebral ischemia; Diabetes; Mitochondrial dynamics; Mitochondrial fission and fusion; Rapamycin; SIRT3.

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / metabolism
  • Brain / metabolism
  • Brain Injuries* / complications
  • Brain Ischemia* / metabolism
  • Diabetes Mellitus, Experimental* / metabolism
  • Infarction, Middle Cerebral Artery / drug therapy
  • Male
  • Mitochondrial Dynamics
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury* / complications
  • Reperfusion Injury* / drug therapy
  • Sirolimus / pharmacology
  • Sirolimus / therapeutic use
  • Sirtuin 3* / metabolism
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Sirolimus
  • Sirtuin 3
  • TOR Serine-Threonine Kinases
  • Apoptosis Regulatory Proteins